BPG is committed to discovery and dissemination of knowledge
Featured Articles
9/14/2026 8:15:38 AM | Browse: 1 | Download: 0
 |
Received |
|
2026-02-27 03:11 |
|
Peer-Review Started |
|
2026-02-27 03:11 |
|
First Decision by Editorial Office Director |
|
2026-03-20 11:25 |
|
Return for Revision |
|
2026-03-20 11:25 |
|
Revised |
|
2026-03-31 17:18 |
|
Publication Fee Transferred |
|
2026-04-27 15:43 |
|
Second Decision by Editor |
|
2026-04-21 02:51 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-04-21 06:29 |
|
Articles in Press |
|
2026-04-21 06:29 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-09-09 00:43 |
|
Publish the Manuscript Online |
|
2026-09-14 06:00 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Cohort Study |
| Article Title |
Baseline cytokines and programmed death-ligand 1 prognostic value in advanced gastric cancer with sintilimab plus chemotherapy
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Yong-Cheng Li, Di Pan, Hao-Nan Liu, Zi-Cheng Pei, Yu-Qi Li, Zheng-Xiang Han and Wen-Lou Liu |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Wen-Lou Liu, MD, PhD, Department of Oncology, The Affiliated Hospital of Xuzhou Medical University, No. 99 Kunpeng Road, Xuzhou Economic and Technological Development Zone, Xuzhou, Jiangsu, China, Xuzhou 221000, Jiangsu Province, China. liuwenlou@163.com |
| Key Words |
Gastric cancer; Cytokines; Immunotherapy; Efficacy; Sintilimab; Overall survival; Interleukins |
| Core Tip |
This study explores advanced gastric cancer (AGC) patients receiving first-line sintilimab plus chemotherapy, identifying baseline interleukin (IL)-6, IL-10, IL-17 and programmed death-ligand 1 as independent overall survival prognostic factors. A well-validated nomogram model is established, and these peripheral blood indices serve as novel biomarkers for screening AGC patients who benefit from immunotherapy. |
| Publish Date |
2026-09-14 06:00 |
| Citation |
Li YC, Pan D, Liu HN, Pei ZC, Li YQ, Han ZX, Liu WL. Baseline cytokines and programmed death-ligand 1 prognostic value in advanced gastric cancer with sintilimab plus chemotherapy. World J Gastroenterol 2026; 32(40): 120447
|
| URL |
https://www.wjgnet.com/1007-9327/full/v32/i40/120447.htm |
| DOI |
https://doi.org/10.3748/wjg.120447 |
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.
